Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Adrenal steroids in adrenomyeloneuropathy
by
Grigull, Andreas
, Stoffel-Wagner, Birgit
, Köhler, Wolfgang
, Wichers-Rother, Maria
, Sokolowski, Piotr
2005
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Adrenal steroids in adrenomyeloneuropathy
by
Grigull, Andreas
, Stoffel-Wagner, Birgit
, Köhler, Wolfgang
, Wichers-Rother, Maria
, Sokolowski, Piotr
2005
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Adrenal steroids in adrenomyeloneuropathy
2005
Request Book From Autostore
and Choose the Collection Method
Overview
Adrenoleukodystrophy (ALD) and its adult variant adrenomyeloneuropathy (AMN) are X-linked diseases associated with a deficiency in the peroxisomal degradation of saturated very long chain fatty acids (VLCFA) resulting in an accumulation of VLCFA in the central and peripheral myelin, the adrenal cortex and the testis. Adrenal insufficiency with clinical hypocortisolism occurs in approximately two thirds of the patients with AMN.We studied the circulating adrenal hormones17α-hydroxyprogesterone (17α-OHP), androstenedione and dehydroepiandrosterone sulphate (DHEAS) in 63 male AMN patients (age 17-65 years) and the DHEAS serum levels in 95 healthy male controls (age 30-65 years). 34 of the patients presented with the phenotype of only spinal cord and peripheral nerve disability without hypocortisolism, 29 of the patients presented with the phenotype of either additional hypocortisolism or Addison's syndrome only. Normal 17α-OHP concentrations were found in all patients with no significant difference between patients without and with hypocortisolism (6.07±0.61 nmol/l and 4.76±0.37 nmol/l). Androstenedione concentration was significantly (p<0.01) lower in patients with hypocortisolism (2.99±0.65 pmol/l versus 5.71±0.68 pmol/l). As serum levels of DHEAS are agedependent we divided the two groups into two subgroups each (subgroup one: age 17-40 years, subgroup two: age 41-65 years). The DHEAS concentration of patients without and with hypocortisolism was significantly (p<0.01) lower in both subgroups (1. 4.35±0.84 µmol/l, n=15, 2. 15±0.28 µmol/l, n=19; 1. 1.90±0.57 µmol/, n=21, 2. 0.96±0.29 µmol/l, n=8) compared to controls (1. 9.0±0.96 µmol/l; 2. 5.21±0.25 µmol/l). In conclusion, androstenedione and DHEAS serum concentrations are subnormal in all AMN patients and may therefore serve as sensitive markers of the adrenal function in adrenomyeloneuropathy.
Publisher
Springer Nature B.V
MBRLCatalogueRelatedBooks
Related Items
Related Items
We currently cannot retrieve any items related to this title. Kindly check back at a later time.
This website uses cookies to ensure you get the best experience on our website.